Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:41:18.975Z.
Calculation as of: 2026-10-06T22:41:18.975Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5d6bd3278d76725a85d4cb05495e45b99d0fd89b23371e3701c8289362793e8f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Design Therapeutics, Inc.
Market Cap
$747.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.02M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.37M
Operating Cash Flow Yield
7.31%
TTM Avg
8.35%
3Y Avg
7.91%
5Y Avg
6.12%
Market Cap
$765.30M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$723.18M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$721.69M
Operating Cash Flow Yield
N/A
TTM Avg
23.08%
3Y Avg
23.11%
5Y Avg
23.11%
Market Cap
$776.24M
Operating Cash Flow Yield
N/A
TTM Avg
1.73%
3Y Avg
1.73%
5Y Avg
1.73%
Market Cap
$777.34M
Operating Cash Flow Yield
N/A
TTM Avg
46.70%
3Y Avg
46.70%
5Y Avg
28.34%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Design Therapeutics, Inc. (DSGN) | $747.61M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 7.31% | 8.35% | 7.91% | 6.12% |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | 23.08% | 23.11% | 23.11% |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 1.73% | 1.73% | 1.73% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | N/A | 46.70% | 46.70% | 28.34% |
| Varex Imaging Corporation (VREX)vs › | $778.01M | 1.45% | 5.82% | 10.97% | 8.65% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
